Enko Chem, Inc. has publicly launched after securing US$45 million in a Series B round of financing, bringing its total funding raised to date to US$66 million. Led by the Bill & Melinda Gates Foundation, the latest round attracted a strong mix of existing (Anterra Capital and Rabobank) and new (Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food) investors.
Latham & Watkins LLP represented Enko Chem, Inc. in the financing with a Boston-based corporate team led by partner Kristen Grannis, with associates Spencer Ricks, Peter Prial, and Tyler Mills.
LEGAL DESIRE NEWSLETTER
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.